Notes d’épisode
Episode 156 — 01 November 2026
This episode examines FDA's new RWE guidance, CMS Star Rating changes, NICE's digital therapeutics framework, and the first wave of EU oncology JCAs.
Hosted by Marcus and Sara.
Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.
Full transcript and sources at outcomes-analytica.no/podcast

